Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

EUA

Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTIOct 30, 2021 10:03 AM +05:30 IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 04:14 PM +05:30 IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 09:29 AM +05:30 IST
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: ReportSwarajya StaffJul 7, 2021 11:42 AM +05:30 IST
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent Efficacy
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent EfficacySwarajya StaffJun 15, 2021 03:06 PM +05:30 IST
Pfizer Likely To Seek US FDA Nod In September For Use Of Its COVID-19 Vaccine In Kids Aged Between 2 To 11 Years
Pfizer Likely To Seek US FDA Nod In September For Use Of Its COVID-19 Vaccine In Kids Aged Between 2 To 11 YearsIANSMay 5, 2021 01:44 PM +05:30 IST
Zydus Cadila Begins Advance Production Of Its COVID Vaccine Candidate; To Seek Emergency Use Approval In May Or June: Report
Zydus Cadila Begins Advance Production Of Its COVID Vaccine Candidate; To Seek Emergency Use Approval In May Or June: ReportSwarajya StaffApr 24, 2021 01:55 PM +05:30 IST
Zydus Cadila's 'Virafin' Gets Emergency Use Approval From DCGI For Treating Moderate Covid-19 Infections
Zydus Cadila's 'Virafin' Gets Emergency Use Approval From DCGI For Treating Moderate Covid-19 InfectionsSwarajya StaffApr 24, 2021 10:10 AM +05:30 IST
First Batch Of Russian Sputnik V Covid-19 Vaccine Likely To Reach India By April End: Indian Envoy To Russia
First Batch Of Russian Sputnik V Covid-19 Vaccine Likely To Reach India By April End: Indian Envoy To RussiaSwarajya StaffApr 16, 2021 08:43 AM +05:30 IST
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's Recommendation
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's RecommendationSwarajya StaffApr 13, 2021 08:06 AM +05:30 IST
Vaccine Rollout In A Pandemic: Why Prioritised Access Drives Public Policy
Vaccine Rollout In A Pandemic: Why Prioritised Access Drives Public PolicySuraj SApr 8, 2021 01:26 PM +05:30 IST
With Phase 3 Trials Almost Complete, Dr Reddy's Seeks DCGI Nod For Emergency Use Of Russian Sputnik V Covid Vaccine
With Phase 3 Trials Almost Complete, Dr Reddy's Seeks DCGI Nod For Emergency Use Of Russian Sputnik V Covid Vaccine Swarajya StaffFeb 20, 2021 11:44 AM +05:30 IST
Big Boost For India's Fight Against Covid-19: Serum Institute's Covishield, Bharat Biotech's Covaxin Granted Emergency Use Approval
Big Boost For India's Fight Against Covid-19: Serum Institute's Covishield, Bharat Biotech's Covaxin Granted Emergency Use ApprovalSwarajya StaffJan 3, 2021 11:44 AM +05:30 IST
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's CovaxinSwarajya StaffJan 3, 2021 08:20 AM +05:30 IST
WHO Approves Pfizer-BioNTech Covid-19 Vaccine For Emergency Use After Reviewing Its Safety And Efficacy
WHO Approves Pfizer-BioNTech Covid-19 Vaccine For Emergency Use After Reviewing Its Safety And EfficacyIANSJan 1, 2021 01:51 PM +05:30 IST
Moderna's Covid-19 Vaccine Gets FDA Panel's Endorsement, Set To Be Cleared For Emergency Use Approval
Moderna's Covid-19 Vaccine Gets FDA Panel's Endorsement, Set To Be Cleared For Emergency Use ApprovalIANSDec 18, 2020 09:38 AM +05:30 IST
US FDA Approves Emergency Use Of Anti-Viral Drug Remdesivir For Covid-19 Patients
US FDA Approves Emergency Use Of Anti-Viral Drug Remdesivir For Covid-19 PatientsIANSMay 2, 2020 11:14 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype